{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:20:07Z","timestamp":1792606807306,"version":"4.5.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.arcmed.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T23:26:06Z","timestamp":1629588366000},"page":"798-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Peptides as Therapeutic Molecules to Neutralize Gram-negative Bacterial Lipopolysaccharides in Sepsis and Septic Shock"],"prefix":"10.1016","volume":"52","author":[{"given":"Ismael","family":"Luna-Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er\u00e9ndira Guadalupe","family":"P\u00e9rez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-3302","authenticated-orcid":false,"given":"Blanca","family":"Delgado-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8007-6993","authenticated-orcid":false,"given":"Jaime","family":"Mas-Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2021.08.001_bib0001","first-page":"e1403","article-title":"A Review on Antibiotic Resistance: Alarm Bells are Ringing","volume":"9","author":"Bin","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SHK.0b013e318277109c","article-title":"DAMPs, PAMPs, and the origins of SIRS in bacterial sepsis","volume":"39","author":"Gentile","year":"2013","journal-title":"Shock"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0003","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/CMR.16.3.379-414.2003","article-title":"Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock","volume":"16","author":"Van Amersfoort","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.arcmed.2004.07.006","article-title":"Molecular mechanisms involved in the pathogenesis of septic shock","volume":"35","author":"L\u00f3pez-Boj\u00f3rquez","year":"2004","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/17471060500435662","article-title":"Inflammatory mediators in sepsis: Cytokines, chemokines, adhesion molecules and gases","volume":"2","author":"Ramnath","year":"2006","journal-title":"J Organ Dysfunct"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0006","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system's role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0007","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","article-title":"Sepsis: a roadmap for future research","volume":"15","author":"Cohen","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock","volume":"39","author":"Dellinger","year":"2012","journal-title":"Intensive Care Med 2013"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/13543780903505092","article-title":"Newer antibacterial drugs for a new century","volume":"19","author":"Devasahayam","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0011","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing Sepsis as a Global Health Priority \u2014 A WHO Resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: Where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0013","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/652237","article-title":"The 10 X 20 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020","volume":"50","author":"Gilbert","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/biomedicines8100405","article-title":"Tackling Antibiotic Resistance with Compounds of Natural Origin: A Comprehensive Review","volume":"8","author":"\u00c1lvarez-Mart\u00ednez","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","article-title":"Cell penetrating peptides: A concise review with emphasis on biomedical applications","volume":"108","author":"Derakhshankhah","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/sb300101g","article-title":"Synthetic biology of antimicrobial discovery","volume":"2","author":"Zakeri","year":"2013","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0017","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd3591","article-title":"Designing antimicrobial peptides: form follows function","volume":"11","author":"Fjell","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000336630","article-title":"Cationic Host Defence Peptides: Multifaceted Role in Immune Modulation and Inflammation","volume":"4","author":"Choi","year":"2012","journal-title":"J Innate Immun"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0019","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.chembiol.2010.07.007","article-title":"Structural studies of a peptide with immune modulating and direct antimicrobial activity","volume":"17","author":"Wieczorek","year":"2010","journal-title":"Chem Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri.2016.29","article-title":"The immunology of host defence peptides: beyond antimicrobial activity","volume":"16","author":"Hancock","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0021","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/nbt1113","article-title":"High-throughput generation of small antibacterial peptides with improved activity","volume":"23","author":"Hilpert","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0022","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0023","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1574-6968.2002.tb11000.x","article-title":"Role of membranes in the activities of antimicrobial cationic peptides","volume":"206","author":"Hancock","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0024","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1128\/IAI.67.12.6445-6453.1999","article-title":"Interaction of cationic peptides with lipoteichoic acid and gram- positive bacteria","volume":"67","author":"Scott","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-280X.1998.00160.x","article-title":"Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin","volume":"36","author":"De Lucca","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0026","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0027","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0005-2736(99)00200-X","article-title":"Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by \u03b1-helical antimicrobial and cell non-selective membrane-lytic peptides","volume":"1462","author":"Shai","year":"1999","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1568026615666150703121700","article-title":"Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure","volume":"16","author":"Lee","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0029","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/bip.10260","article-title":"Mode of action of membrane active antimicrobial peptides","volume":"66","author":"Shai","year":"2002","journal-title":"Biopolym-Pept Sci Sect"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/biom8010004","article-title":"Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo","volume":"8","author":"Kumar","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0005-2736(99)00198-4","article-title":"Diversity of antimicrobial peptides and their mechanisms of action","volume":"1462","author":"Epand","year":"1999","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0032","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nbt1288","article-title":"An anti-infective peptide that selectively modulates the innate immune response","volume":"25","author":"Scott","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0033","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","article-title":"Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections","volume":"64","author":"Mookherjee","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0034","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/SHK.0000000000000715","article-title":"Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis","volume":"46","author":"Morton","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0035","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.0901813","article-title":"Synthetic Cationic Peptide IDR-1002 Provides Protection against Bacterial Infections through Chemokine Induction and Enhanced Leukocyte Recruitment","volume":"184","author":"Nijnik","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0036","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.it.2014.07.004","article-title":"Host defense peptides: Front-line immunomodulators","volume":"35","author":"Mansour","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0037","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.176.4.2455","article-title":"Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37","volume":"176","author":"Mookherjee","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0039","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijmm.2007.04.001","article-title":"Structural biology of the LPS recognition","volume":"297","author":"Jerala","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0040","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides: Peptide properties and plausible modes of action","volume":"281","author":"Rosenfeld","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0041","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1517\/14656566.7.6.653","article-title":"Antimicrobial peptides: Therapeutic potential","volume":"7","author":"Zhang","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0042","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0043","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1128\/AAC.00638-15","article-title":"Challenges and solutions for clinical development of new antibacterial agents: Results of a survey among pharmaceutical industry professionals","volume":"59","author":"Bettiol","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0044","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1016\/j.bmc.2016.08.033","article-title":"Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals","volume":"24","author":"Sinha","year":"2016","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-019-0154-y","article-title":"DRAMP 2.0, an updated data repository of antimicrobial peptides","volume":"6","author":"Kang","year":"2019","journal-title":"Sci Data"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0046","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics9010024","article-title":"Development and Challenges of Antimicrobial Peptides for Therapeutic Applications","volume":"9","author":"Chen","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0047","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0048","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/526772","article-title":"Dalbavancin: A novel once-weekly lipoglycopeptide antibiotic","volume":"46","author":"Billeter","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0049","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbamem.2006.02.009","article-title":"Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides","volume":"1758","author":"Straus","year":"2006","journal-title":"Biochim Biophys Acta - Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.30.4.532","article-title":"In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic","volume":"30","author":"Eliopoulos","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.70.1.1","article-title":"Studies on a bactericidal agent extracted from a soil bacillus: I. Preparation of the agent. Its activity in vitro","volume":"70","author":"Dubos","year":"1939","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0052","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1574-6976.2003.tb00628.x","article-title":"Mechanism of action of oritavancin and related glycopeptide antibiotics","volume":"26","author":"Allen","year":"2003","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0053","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","article-title":"Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus","volume":"49","author":"Higgins","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0054","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/clinids\/3.Supplement_2.S200","article-title":"Introduction to Vancomycin","volume":"3","author":"Griffith","year":"1981","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10989-019-09823-5","article-title":"A Review on Bioactive Peptides: Physiological Functions, Bioavailability and Safety","volume":"26","author":"Bhandari","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0056","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0057","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.chembiol.2006.08.014","article-title":"Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides","volume":"13","author":"Hilpert","year":"2006","journal-title":"Chem Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0058","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnins.2017.00073","article-title":"Membrane active antimicrobial peptides: Translating mechanistic insights to design","volume":"11","author":"Li","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0059","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/jm8015365","article-title":"Identification of novel antibacterial peptides by chemoinformatics and machine learning","volume":"52","author":"Fjell","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1021\/cb800240j","article-title":"Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs","volume":"4","author":"Cherkasov","year":"2009","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0061","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1747-0285.2007.00543.x","article-title":"Evaluating Different Descriptors for Model Design of Antimicrobial Peptides with Enhanced Activity Toward P. aeruginosa","volume":"70","author":"Jenssen","year":"2007","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0062","doi-asserted-by":"crossref","first-page":"e12684","DOI":"10.1371\/journal.pone.0012684","article-title":"Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0063","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1348-0421.2002.tb02759.x","article-title":"Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions","volume":"46","author":"Hamamoto","year":"2002","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0064","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4236\/abb.2011.26059","article-title":"Degradation of naturally occurring and engineered antimicrobial peptides by proteases","volume":"2","author":"Moncla","year":"2011","journal-title":"Adv Biosci Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0065","doi-asserted-by":"crossref","first-page":"14130","DOI":"10.1021\/bi035643g","article-title":"Structure-based design of an indolicidin peptide analogue with increased protease stability","volume":"42","author":"Rozek","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0066","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.idairyj.2007.11.009","article-title":"Use of nisin and other bacteriocins for preservation of dairy products","volume":"18","author":"Sobrino-L\u00f3pez","year":"2008","journal-title":"Int Dairy J"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0067","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41573-019-0058-8","article-title":"Antimicrobial host defence peptides: functions and clinical potential","volume":"19","author":"Mookherjee","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0068","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.bbamem.2015.02.017","article-title":"Understanding bacterial resistance to antimicrobial peptides: From the surface to deep inside","volume":"1848","author":"Maria-Neto","year":"2015","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0069","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1441","article-title":"The co-evolution of host cationic antimicrobial peptides and microbial resistance","volume":"4","author":"Peschel","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1164\/rccm.200504-656OC","article-title":"A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia","volume":"173","author":"Kollef","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(99)00197-2","article-title":"Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes","volume":"1462","author":"Matsuzaki","year":"1999","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0072","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/fmb.11.27","article-title":"Road to clinical efficacy: Challenges and novel strategies for antimicrobial peptide development","volume":"6","author":"Eckert","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0073","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jmb.2009.06.071","article-title":"Coupling Molecular Dynamics Simulations with Experiments for the Rational Design of Indolicidin-Analogous Antimicrobial Peptides","volume":"392","author":"Tsai","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0074","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/bip.20543","article-title":"Advances in antimicrobial peptide immunobiology","volume":"84","author":"Yount","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.tibtech.2007.01.003","article-title":"Expanding the metabolic engineering toolbox: more options to engineer cells","volume":"25","author":"Tyo","year":"2007","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0076","first-page":"359","article-title":"Using Disease-Associated Enzymes to Activate Antimicrobial Peptide Prodrugs","author":"Forde","year":"2017","journal-title":"Antimicrob. Pept. Methods Protoc., New York, NY: Springer New York"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0077","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1023\/A:1022832531473","article-title":"Characterization of a naturally occurring new version of the cholesterol ester transfer protein (CETP) from small intestine","volume":"245","author":"Alonso-Garcia","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0078","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1021\/acs.joc.8b03001","article-title":"Sustainability Challenges in Peptide Synthesis and Purification: From R&D to Production","volume":"84","author":"Isidro-Llobet","year":"2019","journal-title":"J Org Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0079","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/asia.201801807","article-title":"Making Solid-Phase Peptide Synthesis Greener: A Review of the Literature","volume":"14","author":"Varnava","year":"2019","journal-title":"Chem \u2013 An Asian J"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: A web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J Comput Chem"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0081","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"A unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0082","doi-asserted-by":"crossref","first-page":"21370","DOI":"10.1021\/acsomega.9b03035","article-title":"Antimicrobial Peptide Designing and Optimization Employing Large-Scale Flexibility Analysis of Protein-Peptide Fragments","volume":"4","author":"Kumar","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0083","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.sbi.2019.12.021","article-title":"Understanding and modelling the interactions of peptides with membranes: from partitioning to self-assembly","volume":"61","author":"Chen","year":"2020","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0084","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.bbamem.2017.07.008","article-title":"Membrane proteins structures: A review on computational modeling tools","volume":"1859","author":"Almeida","year":"2017","journal-title":"Biochim Biophys Acta-Biomembr"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0085","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bpj.2011.03.057","article-title":"The molecular basis for antimicrobial activity of pore-forming cyclic peptides","volume":"100","author":"Cirac","year":"2011","journal-title":"Biophys J"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0086","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bpj.2018.08.040","article-title":"Peptide-Lipid Interaction Sites Affect Vesicles\u2019 Responses to Antimicrobial Peptides","volume":"115","author":"Shi","year":"2018","journal-title":"Biophys J"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0087","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1529\/biophysj.106.094425","article-title":"Coarse-grained peptide modeling using a systematic multiscale approach","volume":"92","author":"Zhou","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0088","doi-asserted-by":"crossref","first-page":"16091","DOI":"10.1038\/srep16091","article-title":"The C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding Protein","volume":"5","author":"Garc\u00eda-Gonz\u00e1lez","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0089","doi-asserted-by":"crossref","first-page":"14752","DOI":"10.1038\/s41598-021-94224-2","article-title":"Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study","volume":"11","author":"Luna-Reyes","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0090","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1021\/acs.jctc.5b00513","article-title":"CHARMM-GUI Martini Maker for Coarse-Grained Simulations with the Martini Force Field","volume":"11","author":"Qi","year":"2015","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0091","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery","volume":"7","author":"Meng","year":"2012","journal-title":"Curr Comput Aided-Drug Des"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0092","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys Rev"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0093","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s002590050036","article-title":"Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations","volume":"27","author":"Welling","year":"2000","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0094","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jlcr.3634","article-title":"A review of approaches to 18 F radiolabelling affinity peptides and proteins","volume":"62","author":"Morris","year":"2019","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0095","article-title":"Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging","author":"Ebenhan","year":"2014","journal-title":"Biomed Res Int 2014"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0096","article-title":"P\u00e9ptidos derivados del dominio C-terminal de CETPI como mol\u00e9culas bloqueadoras del efecto citot\u00f3xico inducido por lipopolisac\u00e1ridos en septicemia y choque s\u00e9ptico","author":"Mas-Oliva","year":"2014","journal-title":"PCT\/MX2014\/000087; WO2015190903A1,(Patent)"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111890","article-title":"New insights into lipopolysaccharide inactivation mechanisms in sepsis","volume":"141","author":"P\u00e9rez-Hern\u00e1ndez","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.arcmed.2021.08.001_bib0098","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","article-title":"Endotoxemia-menace, marker, or mistake?","volume":"100","author":"Munford","year":"2016","journal-title":"J Leukoc Biol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440921001661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440921001661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:50:37Z","timestamp":1759261837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440921001661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":98,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0188440921001661"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2021.08.001","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides as Therapeutic Molecules to Neutralize Gram-negative Bacterial Lipopolysaccharides in Sepsis and Septic Shock","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS).","name":"copyright","label":"Copyright"}]}}